# Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.

> **NCT00150852** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Geneva** · enrollment: 96 (—)

## Conditions studied

- Wound Infection

## Interventions

- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT00150852
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 96 (—)
- **Last updated:** 2005-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150852, "Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00150852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
